Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSA”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02680041
What this trial is testing

18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 221
Not applicableStudy completedNCT03087903
What this trial is testing

Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

Who this might be right for
Prostate Cancer
University of Colorado, Denver 41
Testing effectiveness (Phase 2)Study completedNCT03347110
What this trial is testing

Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
UCB Biopharma SRL 184
Not applicableEnded earlyNCT02771769
What this trial is testing

Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels

Who this might be right for
Prostatic Neoplasms
Chronix Biomedical Corporation 500
Early research (Phase 1)Study completedNCT02514213
What this trial is testing

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer

Who this might be right for
Prostate Cancer
Inovio Pharmaceuticals 62
Not applicableLooking for participantsNCT07422597
What this trial is testing

Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
Norwegian University of Science and Technology 1,016
Not applicableWithdrawnNCT03495479
What this trial is testing

Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance

Who this might be right for
Prostate Cancer
Omnitura Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT00045227
What this trial is testing

Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI)
Post-approval studies (Phase 4)Study completedNCT06604442
What this trial is testing

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 62
Not applicableLooking for participantsNCT06862856
What this trial is testing

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Specific Antigen
Massachusetts General Hospital 50
Not applicableEnded earlyNCT06715254
What this trial is testing

A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil

Who this might be right for
Tuberculosis
Novartis Pharmaceuticals 152
Large-scale testing (Phase 3)Study completedNCT00065442
What this trial is testing

Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Who this might be right for
Prostate Cancer
Dendreon 512
Testing effectiveness (Phase 2)Active Not RecruitingNCT03471650
What this trial is testing

Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT03600350
What this trial is testing

PTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 19
Testing effectiveness (Phase 2)WithdrawnNCT01561482
What this trial is testing

Study of Metformin With Simvastatin for Men With Prostate Carcinoma

Who this might be right for
Prostate Carcinoma
Nicholas Mitsiades
Large-scale testing (Phase 3)Study completedNCT01307423
What this trial is testing

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic Arthritis
Amgen 529
Early research (Phase 1)Study completedNCT00582140
What this trial is testing

Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 22
Testing effectiveness (Phase 2)Study completedNCT00286806
What this trial is testing

Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Ascenta Therapeutics 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT03361735
What this trial is testing

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
City of Hope Medical Center 25
Not applicableStudy completedNCT03419143
What this trial is testing

Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants

Who this might be right for
Psoriatic Arthritis (PsA)
Bristol-Myers Squibb 190
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation